The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABIVAX SA | SPONSORED ADS | 00370M103 | BBG01JLQNZ03 | 20,276,532 | 1,895,003 | SH | SOLE | 1,895,003 | 0 | 0 | ||
| ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | BBG006D9MR17 | 7,528,000 | 10,000,000 | SH | SOLE | 10,000,000 | 0 | 0 | ||
| AKERO THERAPEUTICS INC | COM | 00973Y108 | BBG00L9211Y8 | 13,192,750 | 565,000 | SH | SOLE | 565,000 | 0 | 0 | ||
| ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | BBG001J2LL66 | 30,686,600 | 1,610,000 | SH | SOLE | 1,610,000 | 0 | 0 | ||
| APOGEE THERAPEUTICS INC | COM | 03770N101 | BBG01H51WYQ5 | 6,985,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| ARVINAS INC | COM | 04335A105 | BBG00LW7YK82 | 41,160,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| C4 THERAPEUTICS INC | COM STK | 12529R107 | BBG00BV2Y9B7 | 21,470,000 | 3,800,000 | SH | SOLE | 3,800,000 | 0 | 0 | ||
| CABALETTA BIO INC | COM | 12674W109 | BBG00MJ3BKW2 | 43,130,000 | 1,900,000 | SH | SOLE | 1,900,000 | 0 | 0 | ||
| CELCUITY INC | COM | 15102K100 | BBG00HKBW0P2 | 25,566,037 | 1,754,704 | SH | SOLE | 1,754,704 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | BBG000FW8LZ9 | 27,840,011 | 701,967 | SH | SOLE | 701,967 | 0 | 0 | ||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | BBG007DHZQR7 | 32,728,233 | 5,566,026 | SH | SOLE | 5,566,026 | 0 | 0 | ||
| DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | BBG0076D3T39 | 88,312 | 92,687 | SH | SOLE | 92,687 | 0 | 0 | ||
| DYNE THERAPEUTICS INC | COM | 26818M108 | BBG00NSGPJD0 | 11,970,000 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | ||
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | BBG00CP3BDD4 | 40,161,133 | 2,901,816 | SH | SOLE | 2,901,816 | 0 | 0 | ||
| HARPOON THERAPEUTICS INC | COM NEW | 41358P205 | BBG00MYNY5B2 | 17,055,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
| IMMUNOVANT INC | COM | 45258J102 | BBG00P5MC0Q8 | 42,130,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | BBG008974342 | 17,947,132 | 1,248,062 | SH | SOLE | 1,248,062 | 0 | 0 | ||
| MERUS N V | COM | N5749R100 | BBG00B8LXMS5 | 130,552,758 | 4,747,373 | SH | SOLE | 4,747,373 | 0 | 0 | ||
| NKARTA INC | COM | 65487U108 | BBG00JXHS9G7 | 18,018,000 | 2,730,000 | SH | SOLE | 2,730,000 | 0 | 0 | ||
| NUVALENT INC | COM | 670703107 | BBG00Z1SLMK5 | 97,951,013 | 1,331,037 | SH | SOLE | 1,331,037 | 0 | 0 | ||
| PHARVARIS N V | COM | N69605108 | BBG00YYCW1N8 | 22,440,000 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
| RAYZEBIO INC | COM | 75525N107 | BBG00XV9FHD5 | 23,850,774 | 383,638 | SH | SOLE | 383,638 | 0 | 0 | ||
| RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | BBG007DLZ601 | 71,253,500 | 1,550,000 | SH | SOLE | 1,550,000 | 0 | 0 | ||
| SAB BIOTHERAPEUTICS INC | COM | 78397T202 | BBG00YHY0G88 | 12,593,254 | 1,831,746 | SH | SOLE | 1,831,746 | 0 | 0 | ||
| SOLENO THERAPEUTICS INC | COM | 834203309 | BBG0024L5B86 | 28,175,000 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | BBG0067L94B2 | 40,545,488 | 1,884,084 | SH | SOLE | 1,884,084 | 0 | 0 | ||
| THIRD HARMONIC BIO INC | COM | 88427A107 | BBG00Z14GXB0 | 7,752,565 | 706,706 | SH | SOLE | 706,706 | 0 | 0 | ||
| VAXCYTE INC | COM | 92243G108 | BBG009PHHPL8 | 69,080,000 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
| VERA THERAPEUTICS INC | CL A | 92337R101 | BBG00Q72WYG3 | 83,821,000 | 5,450,000 | SH | SOLE | 5,450,000 | 0 | 0 | ||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | BBG002H242Z5 | 41,906,332 | 1,924,074 | SH | SOLE | 1,924,074 | 0 | 0 | ||
| VISTAGEN THERAPEUTICS INC | COM | 92840H400 | BBG000BB33L9 | 8,095,500 | 1,575,000 | SH | SOLE | 1,575,000 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | BBG0073DM784 | 99,848,546 | 2,167,793 | SH | SOLE | 2,167,793 | 0 | 0 | ||